Chemistry:Beatrice (psychedelic)

Short description: Psychedelic drug

Beatrice

Names
Preferred IUPAC name 1-(2,5-Dimethoxy-4-methylphenyl)-N-methylpropan-2-amine
Other names 4-Methyl-2,5-dimethoxy-methamphetamine 2-(4-Methyl-2,5-dimethoxyphenyl)ethan-alpha,N-methylamine
Identifiers
CAS Number	92206-37-6 Y
3D model (JSmol)	Interactive image
ChEMBL	ChEMBL19044 Y
ChemSpider	184247 Y
PubChem CID	212480
UNII	4TM7A9W7KW Y
InChI InChI=1S/C13H21NO2/c1-9-6-13(16-5)11(7-10(2)14-3)8-12(9)15-4/h6,8,10,14H,7H2,1-5H3 Y Key: IWYGVDBZCSCJGT-UHFFFAOYSA-N Y
SMILES O(c1cc(c(OC)cc1CC(NC)C)C)C
Properties
Chemical formula	C13H21NO2
Molar mass	223.316 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Y verify (what is YN ?)
Infobox references

Beatrice (also known as MDO-D, MDOM, Béa and 4-methyl-2,5-dimethoxymethamphetamine) is a lesser-known psychedelic drug. It is a substituted methamphetamine and a homolog of 2,5-dimethoxy-4-methylamphetamine (DOM). Beatrice was first synthesized by Alexander Shulgin. In his book PiHKAL, the minimum dosage is listed as 30 mg, and the duration listed as 6–10 hours. Beatrice produces a vague feeling of openness and receptiveness, and causes a stimulative effect. It also causes diarrhea. Very little data exists about the pharmacological properties, metabolism, and toxicity of beatrice.

Legal Status

In the US, this substance is a Schedule I isomer of DOET.

See also

• 4-Methylmethamphetamine
• Phenethylamine
• Psychedelics, dissociatives and deliriants
• Ganesha (psychedelic)